The Holotype Early Access Program was formally announced at ASHI 2014 in Denver, and ran until 2015 July. 24 labs across 13 countries have been trained in the use of Holotype HLA and have genotyped hundreds of their own samples. Three early adopters will present their own experience with Holotype HLA, and Omixon’s CEO, Tim Hague will present full results of the Early Access Program and the Performance Evaluation Study for European CE Marking.

 

Event:   Holotype EAP Success
Room:   Rooms 105 & 106, Savannah International Trade & Convention Center
Date:     September 29, 2015, Tuesday
Time:    12pm-2pm EDT

 

Agenda

• Welcome & Introduction
• Technical presentation on Holotype HLA by Dr. Peter Meintjes
• Early Adopter Talks
• Presentation by Prof. Dimitri Monos
• Presentation by Tim Hague

 

Event password: ASHI2015